GSDME and lung carcinoma: More recently, both chemotherapeutic cisplatin and paclitaxel induce pyroptosis via caspase3/GSDME activation; however, cisplatin triggers the pyroptosis more potently than paclitaxel in lung cancer A549 cells [21].